Search Results - Li eLin
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 studyR... by Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Ruibin Huang, Shuye Wang, Zeping Zhou, Guolin Yuan, Meijuan Huang, Li-E Lin, Shifeng Lou, Yanping Song, Qingchi Liu, Hu Zhou, Heng Mei, Yu Hu
Published in The Lancet Regional Health. Western Pacific (2024-06-01)Get full text
Article -
4
Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China by Qiu-Yuan Xiang, Jing-Song Wu, Ling Huang, Zong-Kai Zou, Ting-Bo Liu, Zhi-Gang Peng, Li-E. Lin, Xiao-Lei Wei, Hong-Yu Zhang, Yun Lin, Guo-Wei Li, Yi-Rong Jiang, Hua Wang, Ke-Qian Shi, Rui-Ji Zheng, Zhi-Jun Han, Xiao Qiu, Wen-Yu Li, Ji-Hao Zhou
Published in Frontiers in Oncology (2025-06-01)Get full text
Article -
5
Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study by Ling Huang, Yong Yang, Zhenyu Zhao, Shengsheng Zhou, Jingsong Wu, Ning Wang, Fen Zhang, Keqian Shi, ChengPing Li, Xiaolei Wei, Hongyu Zhang, Yun Lin, Guowei Li, Hui Zhou, Hanguo Guo, Xinmiao Jiang, Xiaojuan Wei, Feili Chen, Sichu Liu, Caidi Lin, Zhanli Liang, Yilan Huang, Lu Pan, Hui Yang, Yirong Jiang, Yudan Wu, Shuqin Cheng, Huifang Yang, Xiaoqiang Zheng, Xinggui Chen, Xiaoliang Li, GuiNian Huang, Jihao Zhou, Zhigang Peng, Li-e Lin, Tingbo Liu, Wenyu Li
Published in Discover Oncology (2025-07-01)Get full text
Article
